These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 5998855)

  • 21. [Further studies of the incidence of coronary cardiopathy in subjects with peripheral arteriosclerotic obliterating arteriopathy. Clinico-statistical investigations of 1434 cases].
    Meciani L; Ricci G; Boeri S; Sabatini G; Biasi G; Biglioli P
    Minerva Cardioangiol; 1971 Mar; 19(3):147-51. PubMed ID: 5553463
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 24. [Radioisotopic determination of circulation time and skin thermometry in the study of circulatory conditions of the lower limbs in the normal aged and in aged patients with chronic obliterating arteriopathy].
    Tarolo GL; Gatti A; Scotti G
    Radiol Med; 1966 Sep; 52(9):923-43. PubMed ID: 4867415
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of adrenalectomy and lumbar ganglionectomy in the therapy of chronic peripheral obliterating arteriopathy (C.P.O.A.) of the lower extremities].
    Guagliano G; Vittori C; Maurizio A; Taborelli R
    Minerva Chir; 1967 Feb; 22(4):159-70. PubMed ID: 6050194
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combined therapy of thrombangitis obliterans atherosclerotica of the lower extremities by means of lumbar sympathectomy and a vascular active drug].
    Witek R
    Arzneimittelforschung; 1968 Feb; 18(2):156-64. PubMed ID: 5695372
    [No Abstract]   [Full Text] [Related]  

  • 27. [Incidence of latent or manifest coronary disease in patients with peripheral obliterating arteriopathy. Clinico-statistical study of 449 cases].
    Meciani L; Ricci G; Castelli E; Basso P; Trentini R
    Minerva Cardioangiol; 1967 Dec; 15(12):813-23. PubMed ID: 5610483
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ulcers of the lower extremities. Treatment with inositol hexanicotinate].
    Bravo Bernabé PA; Fernández A; Zarraga J; Cruz M; Añorve I
    Prensa Med Mex; 1972; 37(3):151-8. PubMed ID: 4559677
    [No Abstract]   [Full Text] [Related]  

  • 29. [PHARMACOLOGICAL EXPERIMENTS WITH A COMBINATION OF KALLIKREIN AND MESO-INOSITOL HEXANICOTINATE].
    PAGLIANI P; GIOSEFFI G
    Boll Chim Farm; 1964 Jul; 103():504-21. PubMed ID: 14200698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complamine in obliterating peripheral circulatory disorders].
    Kusztos D; Bereczky M; Fono J
    Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 33. [THE VALUE OF ELECTROMYOGRAPHY FOR THE DIFFERENTIAL DIAGNOSIS OF OBLITERATING ENDARTERITIS OF THE LOWER EXTREMITIES].
    IANDA V; KOZAK P
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():1784-8. PubMed ID: 14189565
    [No Abstract]   [Full Text] [Related]  

  • 34. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the differential diagnosis of peripheral arterial occlusive diseases].
    Emmrich R
    Munch Med Wochenschr; 1965 Nov; 107(46):2277-81. PubMed ID: 5899398
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-statistical findings in chronic peripheral obliterating arteriopathy].
    Lombardo F; Gallotti R
    Chir Patol Sper; 1968 Feb; 6():Suppl 6:800-3. PubMed ID: 5743529
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinico-statistical findings on the pathological associations of chronic peripheral obliterating arteriopathies].
    Gallotti R; Taborelli G; Ercoli A
    Chir Ital; 1968 Dec; 20(6):1424-7. PubMed ID: 5201348
    [No Abstract]   [Full Text] [Related]  

  • 39. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 40. [Review of studies on the epidemiology of obliterating arteriopathies in Sicily].
    Scaffidi L
    Minerva Med; 1975 Dec; 66(85):4569-74. PubMed ID: 1196541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.